NEWS

FDA advisers endorse gene therapy to treat form of blindness … – Lawrence Journal World

FDA advisers endorse gene therapy to treat form of blindness …Lawrence Journal WorldDr. Barry Byrne listens to testimony concerning the approval of a potentially breakthrough drug for a form of blindness during a meeting of the The Cellular,&nbsp… Continue reading

Infographic: What is CAR-T Cell Therapy & How Does it Fight Cancer? – Labiotech.eu (blog)

Labiotech.eu (blog)Infographic: What is CAR-T Cell Therapy & How Does it Fight Cancer?Labiotech.eu (blog)You might have heard of CAR-T cell therapy as a “miracle cure” for cancer. The approval of Kymriah, the first CAR-T therapy, made headlines a f… Continue reading

FDA advisory committee vote 16-0 for first even gene therapy for rare blindness – Gears Of Biz

FDA advisory committee vote 16-0 for first even gene therapy for rare blindnessGears Of BizThe Cellular, Tissue and Gene Therapies Advisory Committee voted 16-0 to recommend this new therapy. The FDA usually accepts the recommendations from its advisor… Continue reading

Japanese iPSC On the Cusp of a Stem Cell Revolution: Research Turns to Clinical Applications – Nippon.com

Dr. Zandberg on the Role of Immunotherapy in Head and Neck Cancer – OncLive

Dr. Zandberg on the Role of Immunotherapy in Head and Neck CancerOncLiveWith immunotherapy, these single agents are being combined with targeted agents and with other immunotherapy agents, including durvalumab (Imfinzi), in an effort to enhance the amo… Continue reading

Dr. Pal on the Sequencing of Immunotherapy for Urothelial Carcinoma – OncLive

Dr. Pal on the Sequencing of Immunotherapy for Urothelial CarcinomaOncLiveSumanta Kumar Pal, MD, co-director of the Kidney Cancer Program at the City of Hope, discusses the sequencing of immunotherapy regimens in patients with urothelial carcinoma. The… Continue reading